美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,489.44

+9.030.61%

涨家数：5

跌家数：14

平家数：- -

市盈率：- -

高：1,489.90

开：1,480.62

低：1,479.06

收：1,480.41

成交量：7,949.32万

成交额：37.99亿

市值：1.22万亿

流通市值：1.20万亿

数据加载中...

司美格鲁肽心血管获益优于替尔泊肽；全球首个PD-L1 ADC进入III期阶段，来自辉瑞︱掘金创新药

每日经济新闻

《New England Journal of Medicine》发表的危险性休克随机对照试验新数据，证实Impella CP心脏泵的长期生存获益

阿斯利康：巴昔多司他（Baxdrostat）在BaxHTN III期试验中达到主要终点和所有次要终点。巴昔多司他2毫

阿斯利康：在BAXHTN III期试验中巴昔多司他（baxdrostat）使患者的收缩压出现了具有临床意义的降低。阿斯

中期试验受挫后强生宣布放弃开发关节炎联合用药

J&J 放弃开发关节炎联合用药

强生：12周研究结果显示，联合疗法相比单独抗-TNFα疗法未显示充分证据表明具有显著额外获益

强生决定停止Nipocalimab联合抗TNF-α疗法治疗类风湿关节炎的临床开发

FDA批准了更新的莫德纳和辉瑞新冠疫苗用于秋冬病毒季节FDA Approves Updated Moderna and Pfizer COVID-19 Vaccines for Fall and Winter Virus Season

国药集团北京医疗器械有限公司发布雅培电生理产品咨询服务招标

辉瑞Sigvotatug Vedotin启动III期临床适应症为PD-L1高表达的非小细胞肺癌

美国FDA核准三种针对高风险族群的新冠疫苗

美国卫生部长肯尼迪宣布收紧新冠疫苗使用授权辉瑞(PFE.US)等疫苗概念股小幅上涨

背景资料-美国 FDA 批准了哪些新冠疫苗？

美国食品和药物管理局缩小了 65 岁以下人群接种 COVID 疫苗的资格范围；保持了美国老年人的全面接种资格

Moderna：Spikevax疫苗更新配方现已获批用于6个月至64岁人群

Moderna获得美国FDA批准，推出针对Sars-Cov-2 Lp.8.1变异株的更新版新冠疫苗

辉瑞和BioNTech的Comirnaty®获美国FDA批准，适用于65岁及以上成年人和5至64岁新冠重症高风险人群

美国卫生部长肯尼迪表示，FDA 已批准为高危人群注射 COVID 疫苗

Moderna、辉瑞、诺瓦瓦克斯药业股价一度直线拉升消息面上FDA 批准高危人群接种新冠疫苗。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1489.44,"timestamp":1756497599999,"preClose":1480.4108,"halted":0,"volume":79493196,"delay":0,"changeRate":0.006099,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":9.029175,"latestTime":"08-29 16:00:00 EDT","open":1480.6249,"high":1489.9011,"low":1479.0574,"amount":3798804036.646751,"amplitude":0.007325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.863208,"peRate":20.854338,"turnoverRate":0.005177,"increases":5,"decrements":14,"flats":0,"marketCap":1222820844285.5,"floatMarketCap":1203363098255},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1489.9011,"amplitude":0.007325,"preClose":1480.4108,"low":1479.0574,"pbRate":"3.863208","latestPrice":1489.44,"volume":79493196,"delay":0,"open":1480.6249,"prevYearClose":1274.8187,"prevWeekClose":1489.44,"prevMonthClose":1489.44,"prevQuarterClose":1377.5769,"fiveDayClose":1512.8657,"twentyDayClose":1416.0137,"sixtyDayClose":1376.478,"secType":"PLATE","market":"US","turnoverRate":0.005177,"peRate":20.854338,"marketCap":1222820844285.5,"floatMarketCap":1203363098255,"timestamp":1756497599999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":14,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564843111","title":"司美格鲁肽心血管获益优于替尔泊肽；全球首个PD-L1 ADC进入III期阶段，来自辉瑞︱掘金创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2564843111","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564843111?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 22:50","pubTimestamp":1756738252,"startTime":"0","endTime":"0","summary":"资本眼一周行情8月25日—8月29日，医药生物指数上涨0.65%。创新药（BK1106）个股进入分化态势，周内下跌1.72%。恒生医疗保健业指数（HSCICH）周内下跌3.36%，港股创新药创近两个月来最大单周跌幅。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509013501364843.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509013501364843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BBT3K403.USD","LU0456855351.SGD","06978","LU1883839398.USD","IE00BLSP4239.USD","BK1161","LU0306806265.USD","LU0058720904.USD","LU1066053197.SGD","PFE","BK4568","BK4550","LU0234572021.USD","LU1066051498.USD","LU1894683264.USD","LU0985481810.HKD","SG9999003800.SGD","LU0321505439.SGD","BK4581","IE000M9KFDE8.USD","LU0225284248.USD","BK4023","BK4588","SG9999001176.SGD","LU0170899867.USD","LU1023059063.AUD","SG9999011175.SGD","LU0289739699.SGD","PD","BK4534","LU0321505868.SGD","BK4080","SGXZ57979304.SGD","ADC","IE00BLSP4452.SGD","LU0868494617.USD","BK1574","IE00B19Z3B42.SGD","III","BK4533","LU1169589451.USD","LU1894683348.USD","BK4007","BK4134","BK4231","SG9999002232.USD","IE0002270589.USD","LU1057294990.SGD","LU0306807586.USD","SG9999001176.USD"],"gpt_icon":0},{"id":"1177036007","title":"《New England Journal of Medicine》发表的危险性休克随机对照试验新数据，证实Impella CP心脏泵的长期生存获益","url":"https://stock-news.laohu8.com/highlight/detail?id=1177036007","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177036007?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 00:16","pubTimestamp":1756656999,"startTime":"0","endTime":"0","summary":"《New England Journal of Medicine》发表的危险性休克随机对照试验新数据，证实Impella CP心脏泵的长期生存获益","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","LU2602419157.SGD","IE0002141913.USD","BK4534","LU1066051225.USD","LU1244550577.SGD","BK4533","LU2592432038.USD","LU1261432733.SGD","BK4588","LU1718418525.SGD","LU2471134879.HKD","IE00BJT1NW94.SGD","LU1894683348.USD","LU0912757837.SGD","LU2471134523.USD","LU0792757196.USD","LU1244550494.USD","LU2750360641.GBP","LU1162221912.USD","LU1032466523.USD","LU0640476718.USD","BK4559","IE00BVYPNV92.GBP","BK4007","BK4581","LU1674673428.USD","LU0122379950.USD","SG9999001440.SGD","LU1066051811.HKD","LU0345770308.USD","IE00B19Z3B42.SGD","BK4568","IE00BJJMRZ35.SGD","LU2750360997.AUD","IE00BN8TJ469.HKD","LU1778281490.HKD","IE00BLSP4239.USD","BK4592","LU1066053197.SGD","LU2430703178.SGD","IE00B7SZLL34.SGD","IE00BFTCPJ56.SGD","LU2129689431.USD","IE00BGHQF631.EUR","LU1280957306.USD","LU1506573853.SGD","LU1935042991.SGD","IE0009355771.USD","LU1059921491.USD","LU1066051498.USD","IE00B4R5TH58.HKD","LU0795875169.SGD","LU2347655156.SGD","LU0320765646.SGD","LU2112291526.USD","LU1061106388.HKD","IE0034235303.USD","LU1430594728.SGD","IE00B2B36J28.USD","LU2468319806.SGD","IE00B19Z3581.USD","IE00B42XCP33.USD","IE00BDGV0183.EUR","LU2471134796.USD","IE00BFXG1179.USD","LU0058720904.USD","LU2430703251.USD","LU1267930813.SGD","LU0345769631.USD","BK4585","LU0098860793.USD","LU0114720955.EUR","LU0466842654.USD","LU1732800096.USD","LU1032955483.USD","IE00B1BXHZ80.USD","LU2471134952.CNY","BK4504","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU1196500208.SGD","LU1674673691.USD","LU2505996509.AUD","IE000M9KFDE8.USD","LU1914381329.SGD","LU1732799900.SGD","LU1221951046.USD","IE00B3PB1722.GBP","BK4532","IE00B3T34201.USD","LU0234570918.USD","IE0002270589.USD","LU1221951129.SGD","LU2430703095.HKD","LU2505996681.GBP","BK4550","LU0203345920.USD","LU0345769128.USD","LU0234572021.USD","LU0889566641.SGD","LU0070217475.USD","SG9999002224.SGD","LU1057294990.SGD","IE00BLSP4452.SGD","LU0795875086.SGD","LU0882574055.USD","IE00BVYPNW00.USD","LU1023059063.AUD","LU1585245621.USD","LU2133065610.SGD","LU0345770993.USD","LU1894683264.USD","LU2129689514.USD","LU2129689605.HKD","LU0289739699.SGD","LU1244550221.USD","LU0985320562.USD","LU1929549753.HKD","JNJ","SG9999002232.USD","LU1074936037.SGD","LU0432979614.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"2563886260","title":"阿斯利康：巴昔多司他（Baxdrostat）在BaxHTN III期试验中达到主要终点和所有次要终点。 巴昔 多司他2毫","url":"https://stock-news.laohu8.com/highlight/detail?id=2563886260","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563886260?lang=zh_cn&edition=fundamental","pubTime":"2025-08-30 22:16","pubTimestamp":1756563415,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2417539215.USD","BK4568","III","LU1829250122.USD","LU0109394709.USD","BK4588","LU0320765992.SGD","LU2236285917.USD","LU2462157665.USD","BK4007","BK4585","LU0889565916.HKD","LU2456880835.USD","AZN","BK4134"],"gpt_icon":0},{"id":"2563888629","title":"阿斯利康：在BAXHTN III期试验中巴昔多司他（baxdrostat）使患者的收缩压出现了具有临床意义的降低。 阿斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2563888629","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563888629?lang=zh_cn&edition=fundamental","pubTime":"2025-08-30 22:15","pubTimestamp":1756563336,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["III","BK4134","LU0320765992.SGD","BK4007","AZN","LU1829250122.USD","LU2236285917.USD","LU2417539215.USD","LU0109394709.USD","LU2462157665.USD","BK4585","BK4588","LU0889565916.HKD","BK4568","LU2456880835.USD"],"gpt_icon":0},{"id":"2563409187","title":"中期试验受挫后 强生宣布放弃开发关节炎联合用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2563409187","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563409187?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 10:06","pubTimestamp":1756433200,"startTime":"0","endTime":"0","summary":"强生公司周四表示，由于一项中期试验的结果没有显示出足够的疗效，该公司决定不再继续开发针对一种关节炎患者的联合用药。该公司正在研究将其药物尼泊卡利单抗与一种抗肿瘤坏死因子α治疗相结合，后者有助于阻止炎症。在中期试验中，对于难以治疗的类风湿性关节炎患者，联合疗法未能显示出比单独使用抗肿瘤坏死因子α疗法更显著的疗效。\n\n\r\n            责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/08/29100652791029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU2471134879.HKD","LU0912757837.SGD","LU1066051811.HKD","IE00B4R5TH58.HKD","LU0882574055.USD","LU2750360641.GBP","LU0889566641.SGD","LU0234570918.USD","LU2430703095.HKD","IE00BLSP4239.USD","JNJ","LU0114720955.EUR","LU2129689514.USD","LU0098860793.USD","IE00BJJMRZ35.SGD","LU1244550577.SGD","IE00B3PB1722.GBP","BK4588","LU1162221912.USD","LU1718418525.SGD","LU1894683264.USD","LU2471134523.USD","BK4581","LU0122379950.USD","LU2468319806.SGD","BK4568","LU1196500208.SGD","LU0345769631.USD","LU0640476718.USD","BK4532","LU2505996681.GBP","IE0034235303.USD","LU1506573853.SGD","BK4534","IE00B2B36J28.USD","BK4533","IE0002141913.USD","IE00BVYPNW00.USD","LU1674673428.USD","IE0002270589.USD","BK4550","LU2602419157.SGD","IE00BGHQF631.EUR","IE00B42XCP33.USD","LU1244550221.USD","LU2592432038.USD","LU2505996509.AUD","LU2347655156.SGD","LU1074936037.SGD","LU1066051225.USD"],"gpt_icon":0},{"id":"2563206110","title":"J&J 放弃开发关节炎联合用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2563206110","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563206110?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 05:11","pubTimestamp":1756415499,"startTime":"0","endTime":"0","summary":"J&J 放弃开发关节炎联合用药路透8月28日 - 强生公司（Johnson & Johnson JNJ.N）周四表示，由于一项中期试验的结果没有显示出足够的益处，该公司决定不再继续开发针对一种关节炎患者的联合用药。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nL4S3UK1OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996681.GBP","IE00BLSP4452.SGD","IE00BJJMRZ35.SGD","LU0070217475.USD","LU1244550577.SGD","LU0345769631.USD","LU1732800096.USD","LU0345769128.USD","LU0792757196.USD","LU2471134796.USD","LU2129689605.HKD","LU1066051498.USD","BK4532","LU2750360997.AUD","IE00BFXG1179.USD","LU2112291526.USD","LU0058720904.USD","BK4581","LU2129689514.USD","LU2468319806.SGD","LU1032955483.USD","LU1196500208.SGD","LU2471134879.HKD","LU0882574055.USD","LU1914381329.SGD","IE00BVYPNW00.USD","LU1221951046.USD","JNJ","LU0203347892.USD","LU0432979614.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","IE00BSNM7G36.USD","BK4550","LU0114720955.EUR","BK4007","LU1280957306.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU1585245621.USD","LU0345770308.USD","LU2592432038.USD","LU1221951129.SGD","BK4568","SG9999002232.USD","LU2602419157.SGD","LU2347655156.SGD","IE00B7SZLL34.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"1160750881","title":"强生：12周研究结果显示，联合疗法相比单独抗-TNFα疗法未显示充分证据表明具有显著额外获益","url":"https://stock-news.laohu8.com/highlight/detail?id=1160750881","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160750881?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 05:04","pubTimestamp":1756415066,"startTime":"0","endTime":"0","summary":"强生：12周研究结果显示，联合疗法相比单独抗-TNFα疗法未显示充分证据表明具有显著额外获益","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJT1NW94.SGD","LU2129689431.USD","LU0122379950.USD","IE00B1BXHZ80.USD","LU1032955483.USD","LU1894683264.USD","LU0466842654.USD","BK4007","IE0034235303.USD","LU0234570918.USD","IE00BFTCPJ56.SGD","LU0889566641.SGD","LU2471134523.USD","BK4534","LU2129689605.HKD","LU1674673691.USD","IE00BVYPNV92.GBP","LU1267930813.SGD","LU1059921491.USD","IE00BLSP4239.USD","LU2750360641.GBP","BK4581","LU1032466523.USD","SG9999002232.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0203347892.USD","JNJ","LU0289739699.SGD","LU1261432733.SGD","BK4533","LU0795875086.SGD","LU0792757196.USD","LU2430703178.SGD","LU2505996509.AUD","BK4568","IE00B19Z3B42.SGD","LU1732799900.SGD","LU0345769128.USD","LU0640476718.USD","LU0114720955.EUR","LU1718418525.SGD","LU2750360997.AUD","IE00BLSP4452.SGD","LU1914381329.SGD","LU2129689514.USD","LU1732800096.USD","IE00BFXG1179.USD","LU1023059063.AUD","LU0985320562.USD","LU1066051498.USD","LU1244550221.USD","LU1778281490.HKD","LU0795875169.SGD","LU1894683348.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4550","IE0002270589.USD","LU0345769631.USD","IE00BSNM7G36.USD","LU1506573853.SGD","LU2347655156.SGD","LU2133065610.SGD","LU2471134796.USD","IE00B42XCP33.USD","LU0320765646.SGD","IE00B3T34201.USD","BK4559","LU2089984988.USD","IE00BGHQF631.EUR","LU0234572021.USD","LU1074936037.SGD","LU0345770308.USD","SG9999001440.SGD","LU2471134952.CNY","LU0882574055.USD","LU1674673428.USD","LU2112291526.USD","LU2505996681.GBP","LU1280957306.USD","LU2430703095.HKD","LU1061106388.HKD","LU2471134879.HKD","LU1244550577.SGD","LU1244550494.USD","LU2592432038.USD","IE00BN8TJ469.HKD","LU1162221912.USD","BK4504","BK4588","LU1057294990.SGD","BK4592","IE00B3PB1722.GBP","SG9999002224.SGD","IE00BBT3K403.USD","LU0070217475.USD","IE0002141913.USD","LU1221951129.SGD","LU1066051225.USD","LU2468319806.SGD","BK4532","LU1929549753.HKD","LU2602419157.SGD","IE00BDGV0183.EUR","LU1066053197.SGD","LU1066051811.HKD","LU1196500208.SGD","LU0098860793.USD","LU1430594728.SGD","IE000M9KFDE8.USD","LU0432979614.USD","IE00B19Z3581.USD","LU0345770993.USD","LU2430703251.USD","LU1935042991.SGD","LU0203345920.USD","IE00BVYPNW00.USD","LU1221951046.USD","LU0912757837.SGD","LU0058720904.USD","IE00B7SZLL34.SGD","LU1585245621.USD"],"gpt_icon":0},{"id":"1135161797","title":"强生决定停止Nipocalimab联合抗TNF-α疗法治疗类风湿关节炎的临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1135161797","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135161797?lang=zh_cn&edition=fundamental","pubTime":"2025-08-29 05:04","pubTimestamp":1756415060,"startTime":"0","endTime":"0","summary":"强生公司宣布，已决定不再推进Nipocalimab联合抗TNF-α疗法治疗类风湿关节炎的临床开发项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1066051498.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU1066051811.HKD","LU1506573853.SGD","LU0114720955.EUR","IE0009355771.USD","LU1032466523.USD","LU2750360997.AUD","LU1244550577.SGD","LU2471134523.USD","LU0234570918.USD","IE00B4R5TH58.HKD","BK4581","LU0985320562.USD","IE00BFTCPJ56.SGD","LU1894683264.USD","LU0289739699.SGD","LU2505996509.AUD","IE00BBT3K403.USD","LU0070217475.USD","LU2505996681.GBP","IE000M9KFDE8.USD","LU2471134796.USD","LU0345769631.USD","IE0002270589.USD","LU0882574055.USD","LU1674673691.USD","LU0795875169.SGD","LU0122379950.USD","LU1196500208.SGD","LU0098860793.USD","LU2129689431.USD","IE00B2B36J28.USD","IE00BGHQF631.EUR","LU1935042991.SGD","BK4559","IE00B3T34201.USD","IE00BLSP4239.USD","LU0345769128.USD","LU0466842654.USD","IE00BVYPNW00.USD","LU0234572021.USD","LU1244550221.USD","LU1057294990.SGD","LU1430594728.SGD","LU2750360641.GBP","LU1244550494.USD","LU1585245621.USD","IE0002141913.USD","LU1066053197.SGD","LU2430703178.SGD","BK4007","LU0640476718.USD","LU2592432038.USD","BK4504","LU0058720904.USD","IE00BSNM7G36.USD","LU2468319806.SGD","LU0912757837.SGD","IE00B3PB1722.GBP","BK4533","BK4550","LU0203347892.USD","LU0889566641.SGD","LU0203345920.USD","LU2347655156.SGD","IE00B19Z3B42.SGD","SG9999002224.SGD","LU1023059063.AUD","LU0792757196.USD","IE00BFXG1179.USD","LU2430703251.USD","LU1267930813.SGD","JNJ","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU1914381329.SGD","LU1929549753.HKD","BK4588","IE00B7SZLL34.SGD","LU2430703095.HKD","BK4568","LU2602419157.SGD","LU1059921491.USD","IE0034235303.USD","LU2129689514.USD","LU1032955483.USD","LU0345770993.USD","LU0432979614.USD","LU2089984988.USD","LU1894683348.USD","BK4592","LU0795875086.SGD","LU2112291526.USD","LU1221951046.USD","LU2471134952.CNY","LU1732799900.SGD","LU1221951129.SGD","LU1280957306.USD","LU1778281490.HKD","LU1261432733.SGD","LU1162221912.USD","IE00BVYPNV92.GBP","IE00BDGV0183.EUR","LU1074936037.SGD","SG9999002232.USD","IE00BJT1NW94.SGD","LU2133065610.SGD","IE00BLSP4452.SGD","BK4585","IE00B42XCP33.USD","LU0345770308.USD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU1732800096.USD","LU1718418525.SGD","BK4534","LU1066051225.USD","LU2471134879.HKD","LU1674673428.USD","LU2129689605.HKD","LU0320765646.SGD"],"gpt_icon":0},{"id":"2563013649","title":"FDA批准了更新的莫德纳和辉瑞新冠疫苗用于秋冬病毒季节FDA Approves Updated Moderna and Pfizer COVID-19 Vaccines for Fall and Winter Virus Season","url":"https://stock-news.laohu8.com/highlight/detail?id=2563013649","media":"动脉网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563013649?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 20:06","pubTimestamp":1756382760,"startTime":"0","endTime":"0","summary":"The decision comes as health officials prepare for potential surges in COVID-19 cases during the fall and winter months. Moderna and Pfizer/BioNTech submitted updates to their vaccine formulas aimed at improving efficacy against newer strains circulating globally. The FDA’s authorization follows a review process that evaluated safety, effectiveness, and adaptability of the updated vaccines to current public health needs..该决定是在卫生官员为秋冬季节可能出现的新冠病例激增做准备之际作出的。莫德纳和辉瑞/生物新技术公司提交了针对其疫苗配方的更新，旨在提高对全球流行的新型毒株的有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508282009339502e491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508282009339502e491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4201","BK4568","LU0225771236.USD","LU0306806265.USD","SG9999013999.USD","SG9999003800.SGD","BK4592","IE00B19Z3B42.SGD","SG9999002224.SGD","BK4534","LU0234572021.USD","SGXZ57979304.SGD","BK4551","IE0002270589.USD","LU1057294990.SGD","LU1066053197.SGD","SG9999011175.SGD","LU1883839398.USD","LU1023059063.AUD","LU1066051498.USD","PFE","BK4588","IE000M9KFDE8.USD","LU0321505439.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","BK4581","BK4550","BK4139","IE00B19Z3581.USD","BK4007","E","LU1894683264.USD","LU0985481810.HKD","BK4599","BK4548","LU1894683348.USD","BK4533","LU0306807586.USD","BK4585","LU0321505868.SGD","IE00BBT3K403.USD","LU0289739699.SGD","LU0868494617.USD","BNTX","LU0225284248.USD","IE00BLSP4239.USD","LU0058720904.USD","LU0122379950.USD"],"gpt_icon":1},{"id":"2563099113","title":"国药集团北京医疗器械有限公司发布雅培电生理产品咨询服务招标","url":"https://stock-news.laohu8.com/highlight/detail?id=2563099113","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563099113?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 19:58","pubTimestamp":1756382283,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月28日，国药集团北京医疗器械有限公司在北京市发布雅培电生理产品咨询及技术支持服务项目的公开招标公告。该项目由采购人国药集团北京医疗器械有限公司发起，目前处于招标公告阶段，未公布中标金额和供应商信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508281959269502dfaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508281959269502dfaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0868494617.USD","LU2237957902.USD","LU1621767737.EUR","T","LU0211326839.USD","LU0496365809.HKD","LU2133065610.SGD","SGXZ23171101.USD","LU0149725797.USD","BK4504","BK4515","BK4598","LU1721429741.USD","LU1989763427.SGD","IE00BFTCPJ56.SGD","BK4585","LU1914381329.SGD","LU1989763690.USD","SG9999004303.SGD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU2211815571.USD","LU2384288077.EUR","SG9999002232.USD","BK4592","BK4581","LU2112291526.USD","ABT","BK4533","LU2237957811.SGD","LU2089984988.USD","SG9999002224.SGD","LU1721429402.USD","IE0002141913.USD","LU0882574055.USD","LU1057294990.SGD","LU1621768206.USD","BK4550","LU0122379950.USD","IE00B4R5TH58.HKD","BK4082","BK4507","BK4568","IE00BSNM7G36.USD","LU1571399168.USD","LU0234572021.USD","LU0976567544.SGD","LU1621767810.EUR","IE00B2B36J28.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2562170031","title":"辉瑞Sigvotatug Vedotin启动III期临床 适应症为PD-L1高表达的非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2562170031","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562170031?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 12:03","pubTimestamp":1756353780,"startTime":"0","endTime":"0","summary":"本次试验主要目的为证明Sigvotatug Vedotin + 帕博利珠单抗在延长OS和BICR评估的PFS方面优于帕博利珠单抗单药；次要目的包括比较两组间BICR评估的客观缓解率，评价其他有效性指标，评估安全性和耐受性特征，以及评估联合给药时的药代动力学和免疫原性。Sigvotatug Vedotin为生物制品，适应症为PD-L1高表达的非小细胞肺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082812485395021e2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082812485395021e2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IE00BBT3K403.USD","LU1169589451.USD","SG9999013999.USD","BK4533","LU0122379950.USD","LU0170899867.USD","LU0306806265.USD","SG9999003800.SGD","BK4599","BK4568","LU0321505439.SGD","LU1894683264.USD","PFE","LU1883839398.USD","IE00B19Z3B42.SGD","BK4201","LU0234572021.USD","LU0225771236.USD","BK4134","SGXZ57979304.SGD","LU0225284248.USD","LU0306807586.USD","IE00BLSP4452.SGD","BK4007","LU0985481810.HKD","E","LU1169590202.USD","LU1066051498.USD","LU1066053197.SGD","BK4534","LU1894683348.USD","IE000M9KFDE8.USD","BK4023","III","IE00B19Z3581.USD","LU0456855351.SGD","BK4550","IE0002270589.USD","IE00BLSP4239.USD","SG9999001176.USD","BK4581","LU0321505868.SGD","BK4588","PD","SG9999002232.USD","LU1057294990.SGD","LU0058720904.USD","BK4592","LU0868494617.USD"],"gpt_icon":1},{"id":"2562779427","title":"美国FDA核准三种针对高风险族群的新冠疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2562779427","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562779427?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 09:15","pubTimestamp":1756343745,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4592","LU0225771236.USD","LU0985481810.HKD","PFE","SG9999002232.USD","BK4547","IE0002270589.USD","LU0122379950.USD","SG9999011175.SGD","SG9999003800.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU0289739699.SGD","LU0868494617.USD","LU1057294990.SGD","BK4585","LU1066051498.USD","SG9999013999.USD","SG9999001176.SGD","LU0321505439.SGD","IE00BLSP4452.SGD","BK4550","BK4007","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU0234572021.USD","BK4139","SG9999001176.USD","IE00BBT3K403.USD","NVAX","BK4568","BK4534","159646","LU0306806265.USD","IE00B19Z3581.USD","BK4581","BK4599","IE00BLSP4239.USD","LU0321505868.SGD","BK4588","LU1023059063.AUD","LU0170899867.USD","BK4533","LU0058720904.USD","LU0306807586.USD","LU0225284248.USD","LU1894683348.USD","LU1066053197.SGD","LU1894683264.USD","LU1883839398.USD"],"gpt_icon":0},{"id":"2562775299","title":"美国卫生部长肯尼迪宣布收紧新冠疫苗使用授权 辉瑞(PFE.US)等疫苗概念股小幅上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2562775299","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562775299?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 06:00","pubTimestamp":1756332000,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1894683348.USD","BK4534","BK4568","SG9999001176.USD","SG9999013999.USD","BK4588","IE0002270589.USD","IE000M9KFDE8.USD","LU0234572021.USD","LU1066051498.USD","LU0306806265.USD","SG9999011175.SGD","LU0321505439.SGD","LU1057294990.SGD","SG9999001176.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU0321505868.SGD","BK4599","LU1023059063.AUD","IE00BBT3K403.USD","LU0456855351.SGD","PFE","SG9999002224.SGD","BK4585","BK4007","LU0225284248.USD","LU1894683264.USD","LU0170899867.USD","SG9999002232.USD","LU0306807586.USD","BK4592","BK4581","LU0289739699.SGD","LU1066053197.SGD","LU1883839398.USD","BK4550","IE00B19Z3B42.SGD","LU0122379950.USD","IE00BLSP4452.SGD","LU0225771236.USD","LU0868494617.USD","IE00BLSP4239.USD","SG9999003800.SGD","159646","BK4533","LU0985481810.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2562731727","title":"背景资料-美国 FDA 批准了哪些 新冠 疫苗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2562731727","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562731727?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 04:17","pubTimestamp":1756325844,"startTime":"0","endTime":"0","summary":"路透8月27日 - 美国食品和药物管理局已批准  新冠疫苗在美国上市，包括莫德纳MRNA.O和辉瑞PFE.N与合作伙伴BioNTech22UAy.DE生产的基于mRNA的疫苗，以及NovavaxNVAX.O生产的基于蛋白质的传统疫苗。莫德纳莫德纳 公司的 Spikevax 疫苗获批用于 65 岁及以上人群和  6 个月至 64 岁有严重疾病风险的人群。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nL4S3UJ1AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4501","SG9999002224.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999002232.USD","BK4581","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4007","BK4548","IE00BLSP4239.USD","LU0306806265.USD","IE0002270589.USD","MRNA","LU0225771236.USD","NVAX","LU0321505868.SGD","IE00B19Z3581.USD","LU0225284248.USD","LU0456855351.SGD","LU1066053197.SGD","LU0985481810.HKD","LU0234572021.USD","LU1894683264.USD","SG9999013999.USD","BK4550","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU0058720904.USD","LU0321505439.SGD","SG9999001176.USD","BK4551","BK4534","LU0122379950.USD","BK4599","SG9999011175.SGD","BK4585","BK4139","PFE","BK4568","BK4533","BK4588","LU0306807586.USD","SG9999003800.SGD","LU1066051498.USD","LU0170899867.USD","BK4592"],"gpt_icon":1},{"id":"2562729992","title":"美国食品和药物管理局缩小了 65 岁以下人群接种 COVID 疫苗的资格范围；保持了美国老年人的全面接种资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2562729992","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562729992?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 01:34","pubTimestamp":1756316095,"startTime":"0","endTime":"0","summary":"更新版 3-美国食品和药物管理局缩小了 65 岁以下人群接种 COVID 疫苗的资格范围；保持了美国老年人的全面接种资格添加了 Aetna 在第 11 段和 IDSA 在第 16 段中提出的意见FDA 限制 65 岁以下高风险人群接种 COVID 疫苗年轻群体的保险覆盖面和接种问题引起关注辉瑞疫苗对 5 岁以下儿童的紧急使用授权被撤销Patrick Wingrove/Sriparna  Roy. 辉瑞公司和 莫德纳 公司的 COVID 疫苗是基于 mRNA 的。美国传染病学会周三表示，它正在与其他医学会合作，以最终确定最新的COVID疫苗接种指南。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nL4T3UJ17X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0985481810.HKD","SG9999002232.USD","BK4548","SG9999001176.USD","BK4533","LU0170899867.USD","LU1894683348.USD","IE00B19Z3581.USD","SG9999013999.USD","LU0306806265.USD","BK4592","LU0289739699.SGD","BK4581","SG9999001176.SGD","BK4550","BK4551","LU1057294990.SGD","BK4007","IE00B19Z3B42.SGD","BK4585","SG9999002224.SGD","LU0868494617.USD","BK4547","MRNA","IE000M9KFDE8.USD","LU0321505868.SGD","LU0306807586.USD","LU0456855351.SGD","LU1023059063.AUD","LU0225284248.USD","SGXZ57979304.SGD","LU1894683264.USD","BK4139","BK4568","LU1883839398.USD","LU0234572021.USD","IE00BBT3K403.USD","LU0122379950.USD","BK4532","LU0058720904.USD","LU1066051498.USD","NVAX","IE0002270589.USD","BK4588","PFE","BK4501","IE00BLSP4239.USD","SG9999003800.SGD","BK4599"],"gpt_icon":1},{"id":"1193230560","title":"Moderna：Spikevax疫苗更新配方现已获批用于6个月至64岁人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1193230560","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193230560?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 01:34","pubTimestamp":1756316084,"startTime":"0","endTime":"0","summary":"Moderna：Spikevax疫苗更新配方现已获批用于6个月至64岁人群","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","BK4568","MRNA","BK4532","BK4588","BK4501","BK4548","BK4551","BK4533","BK4139"],"gpt_icon":0},{"id":"1177389013","title":"Moderna获得美国FDA批准，推出针对Sars-Cov-2 Lp.8.1变异株的更新版新冠疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1177389013","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177389013?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 01:33","pubTimestamp":1756315998,"startTime":"0","endTime":"0","summary":"Moderna, Inc.已获得美国食品药品监督管理局(FDA)的批准，推出针对Sars-Cov-2 Lp.8.1变异株的更新版新冠疫苗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","MRNA","BK4139","BK4551","BK4533","BK4585","BK4568","BK4532","BK4588","BK4501","BK4548"],"gpt_icon":0},{"id":"1188108503","title":"辉瑞和BioNTech的Comirnaty®获美国FDA批准，适用于65岁及以上成年人和5至64岁新冠重症高风险人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1188108503","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188108503?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 00:50","pubTimestamp":1756313425,"startTime":"0","endTime":"0","summary":"辉瑞和BioNTech的Comirnaty®获美国FDA批准，适用于65岁及以上成年人和5至64岁新冠重症高风险人群","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","SG9999001176.SGD","IE00BLSP4452.SGD","IE0002270589.USD","BK4599","LU0306806265.USD","LU1057294990.SGD","LU1894683348.USD","LU0289739699.SGD","LU0225284248.USD","LU0985481810.HKD","IE00BLSP4239.USD","LU1883839398.USD","SG9999002224.SGD","IE00B19Z3581.USD","BK4007","BK4585","BK4581","LU0122379950.USD","BK4588","LU0321505439.SGD","LU0868494617.USD","LU1066051498.USD","LU0234572021.USD","LU0306807586.USD","LU0225771236.USD","LU1894683264.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.USD","LU0058720904.USD","LU0170899867.USD","IE00BBT3K403.USD","SG9999011175.SGD","BK4568","BK4592","BK4534","IE000M9KFDE8.USD","PFE","BK4533","IE00B19Z3B42.SGD","SG9999013999.USD","LU0321505868.SGD","LU0456855351.SGD","LU1023059063.AUD","BK4550","SG9999002232.USD"],"gpt_icon":0},{"id":"2562980726","title":"美国卫生部长肯尼迪表示，FDA 已批准为高危人群注射 COVID 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2562980726","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562980726?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 00:49","pubTimestamp":1756313391,"startTime":"0","endTime":"0","summary":"美国卫生部长肯尼迪表示，FDA 已批准为高危人群注射 COVID 疫苗路透8月27日 - 美国卫生部长小罗伯特-肯尼迪（Robert F. Kennedy Jr.美国卫生与公众服务部没有立即回应路透的置评请求。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nL4T3UJ170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","SG9999002232.USD","BK4548","SG9999011175.SGD","SG9999001176.USD","BK4533","LU0170899867.USD","LU1894683348.USD","IE00B19Z3581.USD","SG9999013999.USD","LU0306806265.USD","BK4592","LU0289739699.SGD","BK4581","BK4550","BK4551","LU1057294990.SGD","BK4534","BK4007","BK4585","IE00B19Z3B42.SGD","LU0868494617.USD","BK4547","MRNA","IE000M9KFDE8.USD","LU0321505868.SGD","LU0456855351.SGD","LU1023059063.AUD","LU0225284248.USD","SGXZ57979304.SGD","LU1894683264.USD","BK4139","BK4568","LU0234572021.USD","IE00BBT3K403.USD","LU0122379950.USD","BK4532","LU0058720904.USD","LU1066051498.USD","NVAX","IE0002270589.USD","LU0225771236.USD","BK4588","PFE","BK4501","IE00BLSP4239.USD","LU0321505439.SGD","SG9999003800.SGD","BK4599","LU1066053197.SGD"],"gpt_icon":0},{"id":"2562726679","title":"Moderna、辉瑞、诺瓦瓦克斯药业股价一度直线拉升消息面上FDA 批准高危人群接种新冠疫苗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2562726679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562726679?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 00:47","pubTimestamp":1756313257,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE0002270589.USD","LU0868494617.USD","LU1883839398.USD","LU0058720904.USD","LU0234572021.USD","LU1057294990.SGD","LU0306807586.USD","LU1894683264.USD","SG9999002232.USD","SGXZ57979304.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU1066051498.USD","IE00B19Z3581.USD","BK4568","PFE","SG9999013999.USD","BK4599","LU1066053197.SGD","SG9999011175.SGD","SG9999002224.SGD","LU1894683348.USD","LU0321505439.SGD","LU1023059063.AUD","BK4533","BK4585","LU0289739699.SGD","LU0225771236.USD","SG9999003800.SGD","BK4534","SG9999001176.SGD","IE00BBT3K403.USD","LU0170899867.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","159646","BK4588","IE00BLSP4452.SGD","SG9999001176.USD","LU0122379950.USD","BK4007","BK4550","LU0306806265.USD","BK4581","IE00BLSP4239.USD","BK4592","LU0985481810.HKD","LU0225284248.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":76,"code":"91000000","status":"200"}]}}